Antibodies under a microscope

DHJ92702

Research Grade Ligelizumab

Description

CL-2C, CAS: 1322627-61-1

Targets

Ig epsilon chain C region, IGHE, Ig epsilon chain C region ND, Immunoglobulin heavy constant epsilon

Isotype/Mimetic

IgG1-kappa

Animal-Derived Biomaterials Used

None

Sequence Available

No

Original Discovery Method

Unknown

Original Discovery Information Provided On Datasheet

No

Antibody/Binder Origins

Unknown discovery source/method, In vitro recombinant expression